LONG MINI-FUTURE - DEXCOM Stock

DE000VM551G9

Delayed Deutsche Boerse AG 07:47:09 2024-05-20 EDT
2.49 ^EUR	-0.40%

Current month	+11.11%
1 month	-11.35%

Comparison chart between the derivative product and it's underlying value

End-of-day quotes

Chart DEXCOM, INC.

Latest news about DEXCOM, INC.

Dexcom Launches Innovative New Sensor as Groundbreaking Report Reveals Alarming Rates of Anxiety and Depression in Those With Type 2 Diabetes	04:01am	BU
DexCom : Human Rights Statement	05-08	PU
Glutality Powered by StrideMD Announces Integration with Dexcom to Enhance Remote Diabetes Care with CGM Technology	04-30	CI
Wall Street: the worst week of 2024 is followed by the best	04-26	CF

More news

Quotes 5-day view

Date	Price	Change
24-05-20	2.49	-0.40%
24-05-17	2.5	+2.46%
24-05-16	2.44	+5.63%
24-05-15	2.31	+19.69%
24-05-14	1.93	-1.53%

Delayed Quote Deutsche Boerse AG

Last update May 20, 2024 at 07:47 am

More quotes

Static data

Product type	Knock-Out with Stop Loss
Buy / Sell	CALL
Underlying	DEXCOM, INC.
Issuer	Vontobel
WKN	VM551G
ISIN	DE000VM551G9
Date issued	2023-11-29
Strike	104.7 $
Maturity	Unlimited
Parity	10 : 1
Emission price	1.15 €
Emission volume	N/A
Settlement	cash
Currency	EUR

Technical Indicators

Highest since issue	3.6 €
Lowest since issue	0.98 €
Spread	0.05 €
Spread %	2.02%

Company Profile

DexCom, Inc. specializes in the design, manufacture and marketing of continuous glucose monitoring (CGM) systems for people with diabetes and healthcare providers. The company provides an implantable device for continuous measurement of blood glucose levels and an external transmitter to which the sensor transmits glucose levels at specified intervals. The United States accounts for 72.5% of net sales.

Sector

More about the company

Ratings for DexCom, Inc.

Trading Rating

Investor Rating

ESG Refinitiv

B-

More Ratings

Consensus: DexCom, Inc.

Sell

Buy

Mean consensus

BUY

Number of Analysts

Last Close Price

131.4 USD

Average target price

151.2 USD

Spread / Average Target

+15.12%

Consensus